Sign in

CIK 0001098972

  • Accelerated filer
  • Smaller reporting company
Ticker
AGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061562417
Phone
+1 781-674-4410
Business address
3 FORBES ROAD, LEXINGTON, MA, 02421
Former names
ANTIGENICS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-05 Corvese Brian Director Grant or award · Stock Option +100,000 100,000
2026-04-24 Corvese Brian Director Grant or award · Stock Option +210,000 210,000
2025-06-17 Corvese Brian Director Grant or award · Stock Option +750 750
2025-06-17 Corvese Brian Director Grant or award · Stock Option +30,000 30,000
2024-06-11 Corvese Brian Director Grant or award · Stock Option +750 750
2024-02-05 Corvese Brian Director Grant or award · Stock Option +15,000 15,000
2022-02-04 Corvese Brian Director Grant or award · Stock Option (Right to Buy) +150,000 150,000
2021-06-16 Corvese Brian Director Exercise or conversion +22,471 92,085
2021-06-16 Corvese Brian Director Exercise or conversion · Restricted Stock Unit −16,000 16,000
2021-06-15 Corvese Brian Director Grant or award · Stock Option +100,000 100,000
2020-12-17 Corvese Brian Director Grant or award · Stock Option (Right to buy) +100,000 100,000
2020-06-19 Corvese Brian Director Exercise or conversion +21,118 69,614
2020-06-19 Corvese Brian Director Exercise or conversion · Restricted Stock Unit +21,118 0
2020-06-16 Corvese Brian Director Grant or award · Restricted Stock Unit +22,471 49,589
2020-06-16 Corvese Brian Director Grant or award · Stock Option (Right to buy) +2,500 2,500

Page 1 of 1 · 15 trades